IRADIMED CORP. DL-,0001IRADIMED CORP. DL-,0001IRADIMED CORP. DL-,0001

IRADIMED CORP. DL-,0001

No trades
See on Supercharts
Market capitalization
‪480.20 M‬EUR
‪15.58 M‬EUR
‪59.40 M‬EUR
‪7.98 M‬
Beta (1Y)
0.43

About IRADIMED CORP. DL-,0001

CEO
Roger Susi
Headquarters
Winter Springs
Employees (FY)
148
Founded
1992
ISIN
US46266A1097
FIGI
BBG00NRB6J61
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IRADIMED CORP. DL-,0001 stocks are traded under the ticker 46K.
IRADIMED CORP. DL-,0001 is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for IRADIMED CORP. DL-,0001 has a max estimate of 56.6 EUR and a min estimate of 55.6 EUR.
46K earnings for the last quarter are 0.41 EUR per share, whereas the estimation was 0.34 EUR resulting in a 18.35% surprise. The estimated earnings for the next quarter are 0.34 EUR per share. See more details about IRADIMED CORP. DL-,0001 earnings.
IRADIMED CORP. DL-,0001 revenue for the last quarter amounts to ‪15.61 M‬ EUR despite the estimated figure of ‪15.30 M‬ EUR. In the next quarter revenue is expected to reach ‪15.67 M‬ EUR.
Yes, you can track IRADIMED CORP. DL-,0001 financials in yearly and quarterly reports right on TradingView.
46K net income for the last quarter is ‪4.11 M‬ EUR, while the quarter before that showed ‪4.79 M‬ EUR of net income which accounts for −14.20% change. Track more IRADIMED CORP. DL-,0001 financial stats to get the full picture.
IRADIMED CORP. DL-,0001 dividend yield was 0.32% in 2023, and payout ratio reached 11.10%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 46K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRADIMED CORP. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.
46K reached its all-time high on Mar 29, 2022 with the price of 48.0 EUR, and its all-time low was 14.6 EUR and was reached on Mar 17, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 148.00 employees. See our rating of the largest employees — is IRADIMED CORP. DL-,0001 on this list?
We've gathered analysts' opinions on IRADIMED CORP. DL-,0001 future price: according to them, 46K price has a max estimate of 56.54 EUR and a min estimate of 55.61 EUR. Read a more detailed IRADIMED CORP. DL-,0001 forecast: see what analysts think of IRADIMED CORP. DL-,0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRADIMED CORP. DL-,0001 EBITDA is ‪18.85 M‬ EUR, and current EBITDA margin is 31.73%. See more stats in IRADIMED CORP. DL-,0001 financial statements.